These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8005543)

  • 21. Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block.
    Julkunen H; Kaaja R; Wallgren E; Teramo K
    Obstet Gynecol; 1993 Jul; 82(1):11-6. PubMed ID: 8515908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neonatal antinuclear antibodies and the lupus syndrome].
    Pennec Y; Colin A; Youinou P; Alix D
    Arch Fr Pediatr; 1985; 42(7):517-9. PubMed ID: 3878694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
    Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal autoantibodies and congenital heart block: clues from two consecutive pregnancies, one in which there was congenital complete heart block and one in which the fetus was healthy.
    Horsfall AC; Neu E; Forrest G; Venables PJ; Field M
    Arthritis Rheum; 1998 Nov; 41(11):2079-80. PubMed ID: 9811065
    [No Abstract]   [Full Text] [Related]  

  • 25. A further exploration of the impact of antinuclear antibodies on in vitro fertilization-embryo transfer outcome.
    Ying Y; Zhong YP; Zhou CQ; Xu YW; Ding CH; Wang Q; Li J; Shen XT
    Am J Reprod Immunol; 2013 Sep; 70(3):221-9. PubMed ID: 23480310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block.
    Tonello M; Hoxha A; Mattia E; Zambon A; Visentin S; Cerutti A; Ghirardello A; Milanesi O; Ruffatti A
    Clin Rheumatol; 2017 May; 36(5):1155-1160. PubMed ID: 28204891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serological and immunohistochemical studies in pregnant women with systemic lupus erythematosus].
    Sakui H; Yoshimura Y; Tada S; Tateyama Y; Shiraki M; Kokubo M; Torikai K; Kawakami S; Fukushima M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):249-56. PubMed ID: 2786540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss.
    Sun S; Li C; Kou X; Chen C; Guo F; Zhao A
    Int J Gynaecol Obstet; 2021 Sep; 154(3):492-499. PubMed ID: 33341931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
    Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
    Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti Ro/SSA positive undifferentiated connective tissue disease in a mother with a newborn with complete congenital heart block: a case report.
    Louthrenoo W; Boonyaratavej S; Sittiwangkul R; Sukitawut W
    J Med Assoc Thai; 1998 Aug; 81(8):633-6. PubMed ID: 9737117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of prednisolone given to improve the outcome of in vitro fertilization-embryo transfer in women with antinuclear antibodies.
    Taniguchi F
    J Reprod Med; 2005 Jun; 50(6):383-8. PubMed ID: 16050562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal outcome in women with primary Sjögren's syndrome. A retrospective case-control study.
    Julkunen H; Kaaja R; Kurki P; Palosuo T; Friman C
    Clin Exp Rheumatol; 1995; 13(1):65-71. PubMed ID: 7774105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: a prospective controlled study.
    Harger JH; Rabin BS; Marchese SG
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):419-24. PubMed ID: 2783770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinuclear antibodies in sera of patients with recurrent pregnancy wastage.
    Xu L; Chang V; Murphy A; Rock JA; Damewood M; Schlaff W; Zacur HA
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1493-7. PubMed ID: 2240094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinuclear antibodies predicts a poor IVF-ET outcome: impaired egg and embryo development and reduced pregnancy rate.
    Ying Y; Zhong YP; Zhou CQ; Xu YW; Wang Q; Li J; Shen XT; Wu HT
    Immunol Invest; 2012; 41(5):458-68. PubMed ID: 22429204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies.
    Spence D; Hornberger L; Hamilton R; Silverman ED
    J Rheumatol; 2006 Jan; 33(1):167-70. PubMed ID: 16292791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinuclear autoantibodies, complement level, hypergammaglobulinemia and spontaneous intrauterine hematoma in pregnant women.
    Alijotas J; Izquierdo M; Serra B; Cusido MT; Ribera M; Carrera JM
    Am J Reprod Immunol; 2003 Jul; 50(1):1-6. PubMed ID: 14506922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.
    Jaeggi ET; Fouron JC; Silverman ED; Ryan G; Smallhorn J; Hornberger LK
    Circulation; 2004 Sep; 110(12):1542-8. PubMed ID: 15353508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?
    Reggia R; Ziglioli T; Andreoli L; Bellisai F; Iuliano A; Gerosa M; Ramoni V; Tani C; Brucato A; Galeazzi M; Mosca M; Caporali R; Meroni PL; Tincani A
    Rheumatology (Oxford); 2012 Dec; 51(12):2186-90. PubMed ID: 22923750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
    Makino S; Yonemoto H; Itoh S; Takeda S
    Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.